Grey Wolf Animal Health Corp.
WOLF.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.88% | 34.02% | 30.87% | 23.08% | 5.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.88% | 34.02% | 30.87% | 23.08% | 5.54% |
| Cost of Revenue | 30.36% | 29.08% | 21.82% | 20.12% | 4.67% |
| Gross Profit | 39.35% | 38.79% | 39.06% | 25.86% | 6.42% |
| SG&A Expenses | 5.53% | 29.86% | 32.29% | 13.92% | 5.93% |
| Depreciation & Amortization | 35.05% | 81.97% | 74.27% | 91.09% | 15.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.09% | 31.65% | 28.25% | 20.56% | 5.77% |
| Operating Income | 685.70% | 51.12% | 46.71% | 68.64% | -17.07% |
| Income Before Tax | 198.10% | 12.86% | 15.86% | -58.02% | -76.47% |
| Income Tax Expenses | -2.21% | 23.11% | -6.76% | -7.27% | 50.13% |
| Earnings from Continuing Operations | 165.98% | 8.26% | 28.64% | -79.68% | -71.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 165.98% | 8.26% | 28.64% | -79.68% | -71.54% |
| EBIT | 685.70% | 51.12% | 46.71% | 68.64% | -17.07% |
| EBITDA | 369.29% | 62.03% | 58.60% | 76.83% | 59.38% |
| EPS Basic | 150.35% | -1.68% | 16.91% | -80.00% | -93.24% |
| Normalized Basic EPS | 174.67% | 2.80% | 5.26% | -59.26% | -102.70% |
| EPS Diluted | 135.43% | -1.68% | 6.62% | -80.00% | -118.75% |
| Normalized Diluted EPS | 174.67% | -0.93% | 5.26% | -62.96% | -102.70% |
| Average Basic Shares Outstanding | 31.42% | 10.18% | 10.18% | 0.00% | -11.74% |
| Average Diluted Shares Outstanding | 31.42% | 14.71% | 10.18% | 13.03% | -11.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |